CME/CE

CME/CE Courses

Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

How We Go Wrong in Study Design — Errors and Bias | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), AAPA Category 1 CME Credit, CE for Pharmacists

1.00 CME CE: No experiment or study can be perfect, but if we understand what can go wrong, we can improve our work. Exp 6/30/25

Strategies for Improving Outcomes in CAR T-cell Therapy for DLBCL

Improving Outcomes in CAR T-cell Therapy for DLBCL | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

1.00 CME CE: Patients with DLBCL face poor outcomes with salvage treatments. CAR T-cell therapy shows promise for patients with relapse after chemoimmunotherapy and ASCT. Exp 10/27/23

New Horizons in Precision Oncology: Understanding the Importance of an Identified TSC1 or TSC2 Genetic Alteration - Podcast

Importance of an Identified Genetic Alteration in Precision Oncology | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

0.25 CME CE: TSC1 and TSC2 mutations impact the mTOR pathway and may inform mTOR inhibitor use in solid tumors. Learn about how to identify these mutations using next-generation sequencing. Exp 6/28/24

The New Frontier of Personalized gMG Management: Integrating FcRn Inhibitors Across the Continuum of Care With Point-Counterpoint Case Presentations

The New Frontier of Personalized gMG Management | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

1.00 CME CPE: Myasthenia Gravis: Management With FcRn Inhibitors. The integration of these novel compounds via challenging case studies. Exp 11/22/23

Changing Pharmacological Paradigms for Higher-Risk Myelofibrosis | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

1.00 CME CE: This course discusses how Individuals with intermediate and high-risk myelofibrosis stand to benefit the most from recently approved and investigational agents. Exp 5/19/24

Advances in the Diagnosis and Individualized Treatment of MDS: Molecular Testing, Emerging Therapies, and AML Commonalities

Advances in MDS Diagnosis and Individualized Treatment | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

0.50 CME CE: Multimedia journey about the latest updates on the management of higher-risk MDS and the overlap between MDS and AML with mutated TP53. Exp 3/31/24

10 Questions in Fabry Disease: An Interactive Infographic Guide to Diagnosis, Monitoring, and Comprehensive Patient Management

10 Questions in Fabry Disease | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

0.50 CME CE: Fabry disease CME/CE self-assessment with interactive infographics. Exp 2/28/24

Vision Care: Real-World Tactics to Address Health Inequities | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category 1 CME Credit, ABIM MOC Points, COPE CE Credit(s)

0.75 CME CE: Faculty will guide learners through patient case scenarios reflecting the impact of biases, disparities, and health inequities in vision care. Exp. 11/23/23

The Evolving Integration of Targeted Approaches Across the Multiple Myeloma Spectrum

Integration of Targeted Approaches in Multiple Myeloma | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), CE for Pharmacists

1.00 CME CE: Analysis of various clinical scenarios, interpretation of clinical trials and discussion with MM experts will help guide clinical decisions. Exp 10/27/23

Diagnosing EGPA: Recognizing Signs and Symptoms of the Disease

Diagnosing EGPA: Recognizing Signs and Symptoms | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category 1 CME Credit, ABIM MOC Points

0.50 CME CE: Drs. Wechsler and Dua identify best practices and current guidelines for the clinical evaluation and differential diagnosis of EGPA. Exp. 4/10/24

Experts Unplugged: A Case Challenge Series in Insomnia with Common Comorbidities

Case Challenge in Insomnia and Common Comorbidities | myCME

AMA PRA Category 1 Credit(s)^TM

1.25 CME: Explores practical patient-based approaches to managing insomnia in perimenopause in association with cardiovascular disease. Exp 6/26/24

Leveraging the Benefits of Anti-Obesity Medications: Best Practices for Bariatric Surgery

Benefits of Anti-Obesity Medications in Bariatric Surgery | myCME

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Expert faculty explore best practices for addressing weight regain following bariatric surgery, including overcoming barriers to the use of AOMs. Exp 8/9/24

Your Patient’s Heart Failure is Worsening, What’s Your Next Step?

Next Steps in Worsening Heart Failure | myCME

AMA PRA Category 1 Credit(s)^TM, AANP Contact Hour(s)

1.00 CME CE: Worsening HF marks a critical phase in HFrEF and is associated with poor prognosis. Early identification of worsening HF is critical to improving outcomes in patients. Exp 9/29/24

Ready for a Closeup: Differentiating Inadequate Response and Emotional Blunting During Treatment for Major Depressive Disorder

Emotional Blunting in Major Depressive Disorder Treatment | myCME

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Innovative “cinemeducation” format to view best practices for the management of major depressive disorder and emotional blunting. Exp 9/29/24

Decision Points in Primary Care: Catching Cardiac Amyloidosis Early

Decision Points: Catching Cardiac Amyloidosis Early | NACE

AMA PRA Category 1 Credit(s)^TM, AANP Contact Hour(s)

0.50 CME CE: New therapies for ATTR-CM underscore the importance of early diagnosis to improve outcomes. Exp 9/29/24

Neuromuscular Blockade: Improving Patient Outcomes with Quantitative TOF Monitoring

Neuromuscular Blockade: Quantitative TOF Monitoring | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category 1 CME Credit, ABS CC Credit, ABA MOCA Points

0.75 CME CE: Drs Faulk and Renew help learners to translate data into clinical practice: clinical assessment, qualitative assessment, and quantitative TOF. Exp 9/29/24

Community Practice Connections™: 2nd Annual Optometry Times™ EyeCon

Detection and Appropriate Treatment of Ocular Diseases | myCME

AMA PRA Category 1 Credit(s)^TM, COPE CE Credit(s), CNE Contact Hour(s)

1.50 CME CE: The importance of early detection and appropriate treatment of ocular diseases for maintaining optimal vision and preventing adverse outcomes. Exp 1/31/24

10 Questions in Fabry Disease | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

0.50 CME CE: Fabry disease CME/CE self-assessment with interactive infographics. Exp 2/28/24

Importance of an Identified Genetic Alteration in Precision Oncology | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

Bridging Specialties™: Timely Diagnosis for ILD

Timely Diagnosis for ILD | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

0.50 CME CE: Practical information and tools to help clinicians recognize the signs and symptoms of ILD and understand the diagnostic process. Exp 8/28/24

Burst Advances In™: Emerging Anti-TFPI Targeted Therapies for the Long-Term Prophylaxis of Hemophilia

Anti-TFPI Therapies for Long-Term Hemophilia Prophylaxis | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

0.25 CME CE: Investigating anti-tissue factor plasma inhibitor monoclonal antibodies in hemophilia A/B; concizumab; marstacimab; befovacimab. Exp 8/16/24

Addressing the Unmet Needs of Patients with Acute Hepatic Porphyria

Unmet Needs of Patients with Acute Hepatic Porphyria | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category 1 CME Credit, ABIM MOC Points

1.50 CME CE: Two prominent experts in AHP help clinicians involved in hematology stay current with best practices for managing this disease. Exp 1/27/24

CME/CE Courses

Featured Courses

More